Avadel Pharmaceuticals通过获得来自Xwpharma Ltd的Valiloxybate独家许可,进一步强化其睡眠医学产品组合。
Avadel Pharmaceuticals通过获得来自Xwpharma Ltd的Valiloxybate独家许可,进一步强化其睡眠医学产品组合。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.